CAMBRIDGE, Mass. & SALISBURY, England --(BUSINESS WIRE)--Jan. 8, 2025-- KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) today announced that the compensation committee of KalVista’s board of directors granted nine newly-hired employees inducement options to purchase an aggregate of 61,000 shares of
